Real-World French Prospective Study on Lung Cancer Highlights Progress in NSCLC Since 2000 | Docwire News
Among the 2020 cohort of patients with NSCLC, the three-year survival rate was around 35%, with a median overall survival of 17.4 months.
Related Articles
How Common Is Anxiety, Sleep Disturbance in Patients Undergoing Chemotherapy?
Home > Patient Voice > How Common Is Anxiety, Sleep Disturbance in Patients Undergoing Chemotherapy? More than 40% of patients receiving outpatient oncology treatment reported…
Classes and Stages of Heart Failure
The American Heart Association explains the classes of heart failure. Doctors usually classify patients’ heart failure according to the severity of their symptoms.
Evaluating Outcomes in Follicular Lymphoma: Standard of Care Versus Clinical Trials | Blood Cancers Today
Despite complexities, limited real-world data exist comparing outcomes between SOC and clinical trials for FL across treatment lines.
Study Finds More Plant-Based Protein Reduces Heart Disease Risk
WASHINGTON — Are you trying to add more protein to your diet? Protein-rich foods benefit your muscles, bones, brain, cardiovascular and immune systems. While vegetarians…
New research links plant-based diets to multiple health benefits
A recent study found that plant-based diets, like those of vegans and vegetarians, could significantly improve gut health among other benefits.
Efficacy of SZC for Optimizing RAASi Treatment in DKD | Docwire News
A study examined the efficacy of adding sodium zirconium cyclosilicate (SZC) to allow patients with stage 3-4 diabetic kidney disease to maintain treatment with RAASi.
Clinical Characteristics and Outcomes of Patients With Takotsubo Syndrome and Left Ventricular Outflow Tract Obstruction:
∗Clinical Cardiology Unit, Medicine and Health Science “V. Tiberio” Department, University of Molise, Responsible Research Hospital, Largo Agostino Gemelli 1, 86100 Campobasso, Italy. E-mail: E-mail…
Decoding High Post-TAVR Gradients: Insights From 4 Clinical Scenarios
AbstractEchocardiography is a well-established tool for evaluating bioprosthetic valve performance after transcatheter aortic valve replacement. The presence of higher-than-expected echocardiograph…
Meta-Analysis of Dedicated vs Off-Label Transcatheter Devices for Native Aortic Regurgitation:
AbstractBackgroundTranscatheter aortic valve replacement (TAVR) for high surgical risk patients with severe native aortic regurgitation (AR) presents unique challenges. Dedicated devices such as th…